Because of the high heterogeneity of breast cancer, we classified breast cancer cell lines as hormone-receptor-positive cancer, HER2-positive cancer, and TNBC; the cells were then treated with sulbactam and doxorubicin. This evidence concerns the gene ERBB2 and breast cancer.